📊 Score Breakdown
Offering Ability
60
Cash Runway
95
Float Risk
27
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
61%
💰 Capital Raise
75%
• Critical: only 2.0 months cash remaining
• Active shelf registration ($2M, 15% of market cap)
📉 Score Deterioration
50%
• Score rose 45 points recently (worsening)
• Score in HIGH risk zone (67/100)
🔄 Reverse Split
45%
• 50-day avg $1.93 approaching $1 threshold
• Only 2 months cash — financial pressure
💹 Market Data
Market Cap$13.17M
Shares Outstanding6.06M
Float4.15M
Cash$1.15M
Debt$18.07M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 94.9% shares (2025Q4 vs prior)
10 institutional holders · 839.7K shares
#1
Potomac Capital Management, Inc.
408.4K shares
#2
Summit Trail Advisors, LLC
330.9K shares
#3
DRW Securities, LLC
34.4K shares
+ 7 more holders Sign up free to view →
📉 Short Interest
Short Interest24.7K
Days to Cover1.5
% of Float0.6%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2025
xbrl
XBRL CONVERTIBLE
Dec 31, 2015
4
INSIDER TRANSACTION
Mar 03, 2026
4
INSIDER TRANSACTION
Feb 24, 2026
S-1
SHELF
Feb 04, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for XELB
📊 XELB FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 XELB Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.